Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 466 AL 480

A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease

Moccia M, Erro R, Picillo M, Santangelo G, Spina E, Allocca R, Longo K, Amboni M, Palladino R, Assante R, Pappatà S, Pellecchia MT, Barone P, Vitale C.

Sleep. 2016 Feb 1;39(2):405-12. doi: 10.5665/sleep.5452.

Male brain ages faster: the age and gender dependence of subcortical volumes

Király A, Szabó N, Tóth E, Csete G, Faragó P, Kocsis K, Must A, Vécsei L, Kincses ZT.

Brain Imaging Behav. 2016 Sep;10(3):901-10. doi: 10.1007/s11682-015-9468-3.

TCM, brain function and drug space

Tang C, Ye Y, Feng Y, Quinn RJ.

Nat Prod Rep. 2016 Jan;33(1):6-25. doi: 10.1039/c5np00049a.

Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease

Dong J, Cui Y, Li S, Le W.

Curr Neuropharmacol. 2016;14(4):339-55. doi: 10.2174/1570159x14666151120123025.

A Case of Rapid Eye Movement Sleep Behavior Disorder in Parkinson Disease Treated With Sodium Oxybate

Liebenthal J, Valerio J, Ruoff C, Mahowald M.

JAMA Neurol. 2016 Jan;73(1):126-7. doi: 10.1001/jamaneurol.2015.2904.

Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines

Alam Q, Alam MZ, Mushtaq G, Damanhouri GA, Rasool M, Kamal MA, Haque A.

Curr Pharm Des. 2016;22(5):541-8. doi: 10.2174/1381612822666151125000300.

Review: Parkinson's disease: from synaptic loss to connectome dysfunction

Bellucci A, Mercuri NB, Venneri A, Faustini G, Longhena F, Pizzi M, Missale C, Spano P.

Neuropathol Appl Neurobiol. 2016 Feb;42(1):77-94. doi: 10.1111/nan.12297.

Medicinal-Induced Behavior Disorders

Munjampalli SK, Davis DE.

Neurol Clin. 2016 Feb;34(1):133-69. doi: 10.1016/j.ncl.2015.08.006.

Cognitive and Psychiatric Disturbances in Parkinsonian Syndromes

Zweig RM, Disbrow EA, Javalkar V.

Neurol Clin. 2016 Feb;34(1):235-46. doi: 10.1016/j.ncl.2015.08.010.

Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology

Tyson T, Steiner JA, Brundin P.

J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):275-289. doi: 10.1111/jnc.13449. Epub 2016 Feb 10.

Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease

Mao ZL, Modi NB.

J Clin Pharmacol. 2016 Aug;56(8):974-82. doi: 10.1002/jcph.683. Epub 2016 Jan 18.

Age-Related Sleep Changes and its Implication in Neurodegenerative Diseases

Lyashenko EA, Poluektov MG, Levin OS, Pchelina PV.

Curr Aging Sci. 2016;9(1):26-33. doi: 10.2174/1874609809666151130220219.

Freezing of Gait in Parkinsonism and its Potential Drug Treatment

Zhang LL, Canning SD, Wang XP.

Curr Neuropharmacol. 2016;14(4):302-6. doi: 10.2174/1570159x14666151201190040.

Left Free Wall Accessory Pathway Ablation in the Presence of a Mechanical Mitral Prosthesis

Fontenla A, López-Gil M, Juliá J, Arribas F.

J Cardiovasc Electrophysiol. 2016 Jun;27(6):759-60. doi: 10.1111/jce.12889. Epub 2016 Jan 20.

LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals

Catorce MN, Gevorkian G.

Curr Neuropharmacol. 2016;14(2):155-64. doi: 10.2174/1570159x14666151204122017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias